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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idA 42-year-old HIV-positive man (CD4 count, 29 cells/ml)
developed an asymptomatic papulo-squamous eruption 1 week
after beginning trimethoprim–sulfamethoxazole (TMP–SMX)
(Figure 1). The eruption progressed despite discontinuation ofFigure 1. (A) Anterior trunk: thin, discrete erythematous papules with scale. (B) Pa
Figure 2. Lesional skin immunohistochemistry for T
1201-9712  2013 The Authors. Published by Elsevier Ltd on behalf of International S
http://dx.doi.org/10.1016/j.ijid.2013.09.001TMP–SMX. Three consecutive syphilis serologies (rapid plasma
reagin) with dilutions and serum treponemal IgG antibody were
negative. The patient was referred to the dermatology department.
A lesional skin biopsy demonstrated a superﬁcial and deep mixedlms: discrete, erythematous macules, many with a collarette of scale (panel B).
reponema pallidum demonstrating spirochetes.
ociety for Infectious Diseases. Open access under CC BY-NC-ND license.
Figure 3. Post-therapy: complete clinical resolution of the skin lesions at 6 months after the initial evaluation.
Medical Imagery / International Journal of Infectious Diseases 18 (2014) 104–105 105inﬂammatory inﬁltrate with numerous plasma cells. No mycobac-
terial or fungal organisms were identiﬁed by histochemical stains.
Immunohistochemistry for Treponema pallidum using a red
chromagen showed numerous spirochetes in the epidermis and
dermis, conﬁrming the clinically suspected diagnosis of secondary
syphilis (Figure 2). Empirical therapy for syphilis had not been
initiated due to a documented penicillin allergy. After diagnostic
conﬁrmation, a 4-week course of oral doxycycline 100 mg twice
daily led to complete resolution of the eruption at 6 months
(Figure 3). Syphilis seronegativity highlights a diagnostic challenge
and has been reported in severely immunocompromised patients
such as those with HIV.1,2 A high index of suspicion and decreased
reliance on serologies for diagnosis and follow-up must be
maintained for immunocompromised patients.1 Close clinical
follow-up for evidence of treatment failure and/or recurrent
disease is critical for seronegative patients diagnosed with
syphilis.2,3
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